Capped dipeptide α-Ketoacid inhibitors of the HCV NS3 protease
- 18 November 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (22) , 3325-3328
- https://doi.org/10.1016/s0960-894x(02)00691-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 proteaseBioorganic & Medicinal Chemistry Letters, 2002
- Evolution, synthesis and SAR of tripeptide α-ketoacid Inhibitors of the hepatitis C virus NS3/NS4A serine proteasePublished by Elsevier ,2002
- Inhibition of the Hepatitis C Virus NS3/4A ProteaseJournal of Biological Chemistry, 2000
- Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In VivoJournal of Virology, 2000
- α-Ketoacids Are Potent Slow Binding Inhibitors of the Hepatitis C Virus NS3 ProteaseBiochemistry, 2000
- The Scientific Challenge of Hepatitis CScience, 1999
- Potent Peptide Inhibitors of Human Hepatitis C Virus NS3 Protease Are Obtained by Optimizing the Cleavage ProductsBiochemistry, 1998
- Substrate Specificity of the Hepatitis C Virus Serine Protease NS3Journal of Biological Chemistry, 1997
- Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.Proceedings of the National Academy of Sciences, 1995
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989